S. Trajkova, “Immunoblastic morphology as a possible prognostic indicator for the outcome of the patients with diffuse large B cell lymphoma in era of the rituximab based treatment: single centre experience”, Int J Res Med Sci, vol. 1, no. 2, pp. 47–52, Jan. 2017.